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Plasmepsins IX and X are essential
and druggable mediators of malaria
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Proteases of the malaria parasite Plasmodium falciparum have long been investigated
as drug targets. The P. falciparum genome encodes 10 aspartic proteases called
plasmepsins, which are involved in diverse cellular processes. Most have been studied
extensively but the functions of plasmepsins IX and X (PMIX and PMX) were unknown.
Here we show that PMIX is essential for erythrocyte invasion, acting on rhoptry
secretory organelle biogenesis. In contrast, PMX is essential for both egress and
invasion, controlling maturation of the subtilisin-like serine protease SUB1 in exoneme
secretory vesicles. We have identified compounds with potent antimalarial activity
targeting PMX, including a compound known to have oral efficacy in a mouse model
of malaria.
C
onsiderable work has gone into the synthe-
sis of plasmepsin inhibitors as antimalarials
(1–4). Most efforts have been directed at the
digestive vacuole plasmepsins I to IV (PMI
to PMIV) because of the availability of crys-
tal structures and recombinant proteins. How-
ever, genetic knockouts reveal that these are not
essential for parasite survival (5). Thus, rationally
designed inhibitors of PMI to PMIV likely exert
their antimalarial effects through other targets
(1, 3). PMV, PMIX, and PMX are the only other
plasmepsins expressed in asexual blood-stage
parasites (6). PMV is an essential protease that
processes proteins for export into the host eryth-
rocyte and is a focus of ongoing drug development
efforts (7–9). PMV is, however, quite divergent
from the other plasmepsins (10), and most di-
gestive vacuole plasmepsin inhibitors are not po-
tent against this enzyme (11). PMI to PMIV share
more sequence homology to PMIX and PMX
(10). PMIX and PMX could be the targets of di-
gestive vacuole plasmepsin inhibitors that have
antimalarial activity.
To characterize the functions of PMIX and
PMX in the biology of blood-stage Plasmodium
falciparum parasites, we used new TetR-aptamer
conditional knockdown (KD) technology (12)
(fig. S1), enabling translational repression of the
target gene when anhydrotetracycline (aTc) is
removed from the culture. Using CRISPR-Cas9
editing, we installed the TetR-aptamer regula-
tory system at the PMIX and PMX loci to create
PMIXapt and PMXapt lines (fig. S1). When aTc
levels were lowered in synchronous, early ring-
stage parasites, we observed a major decrease in
target protein levels in late-stage schizonts, in
both PMIXapt and PMXapt (Fig. 1A). This led
to decreased replication, revealing a critical role
for both of these enzymes in parasite survival
(Fig. 1B).
To determine the stage at which the defect
occurred, cell cycle progression was monitored
using highly synchronous ring-stage parasites
cultured under KD (–aTc) or induced (+aTc)
conditions. Flow cytometry revealed that both
PMIXapt and PMXapt developed normally until
they reached segmented schizonts (~44 hours).
At the end of the cycle (between 46 to 52 hours),
similar numbers of PMIXapt schizonts had egressed,
irrespective of PMIX expression status. How-
ever, –aTc cultures featured about one-fourth as
many new rings (Fig. 1C). A similar fourfold de-
crease was seen in –aTc PMXapt cultures (Fig. 1D).
Unlike for PMIXapt, at 52 hours, 80% of PMXapt
parasites had egressed in +aTc cultures, whereas
only 36% had egressed in –aTc cultures. Even
taking the egress defect into account, however,
we observed fewer rings than expected, indicat-
ing an additional invasion phenotype. We further
characterized this by live microscopy of individual
cells (13) (Fig. 1E) and observed similar egress
and invasion impairment (Fig. 1F). Unruptured
schizonts accumulated in the –aTc culture as
merozoite clusters and some distorted schizonts;
occasionally, these partially ruptured or displayed
defective merozoite dispersal (Fig. 1G). Of the
parasites that could egress in a normal time frame
under –aTc conditions, the merozoite invasion
rate was ~50% of that observed in the presence
of aTc (Fig. 1F). These data implicate PMIX in
erythrocyte invasion and PMX in both egress
and invasion. A PMIXapt-PMXapt double aptamer–
tagged line displayed a similar defect in egress
and a greater block in invasion, yielding a sev-
enfold decrease in new rings (fig. S2). The data
imply independent contributions of PMIX and
PMX to these processes.
To evaluate the subcellular localization of these
proteins, we engineered epitope tags on the 3′
end of the endogenous genes (fig. S3) and per-
formed immuno–electron microscopy. PMIX was
found largely in the bulbs of rhoptry secretory
organelles that are involved in invasion (14) (Fig. 2,
A and B). PMX was found in exonemes—small,
ovoid secretory vesicles that discharge during
egress into the parasitophorous vacuole surround-
ing the parasite (15) (Fig. 2, C to E).
The localization studies guided us to examine
organellar proteins whose processing could be
affected by PM action. RAP1 is a rhoptry bulb
protein that is processed from an 84-kDa pre-
cursor to 82- and 67-kDa forms. The PMIXapt line
failed to process the precursor efficiently when
aTc was withdrawn (Fig. 3A). In contrast, the
rhoptry neck protein RON4 was processed de-
spite PMIXKD. By electronmicroscopy, a rhoptry
biogenesis defect was evident under KD condi-
tions (Fig. 2, F and G).
The subtilisin-like serine protease SUB1 is an
exonemal protein that plays a critical role in
egress and invasion (15, 16). SUB1 is synthesized
as an 82-kDa zymogen that rapidly self-processes
into a 54-kDa semi-proenzyme in the endoplasmic
reticulum (ER). The cleaved prodomain remains
bound to the 54-kDa protein and inhibits activity
(17). A second processing step converts the 54-kDa
form into a 47-kDa mature protein. This step can
occur autocatalytically in vitro but is slow and
partial (18, 19). A processing enzyme has been
postulated for this step (20), but its identity is
unclear. Notably, a major defect in SUB1 process-
ing was observed in PMXapt (Fig. 3B) but not
PMIXapt (fig. S4) after aTc withdrawal, indicating
that PMX is important for the final SUB1 pro-
cessing step. Consistent with this, PMX is synthe-
sized and processed shortly before SUB1 synthesis
and processing occurs (Fig. 3C). Similar to the sec-
ond processing step of SUB1, PMX maturation
is blocked by brefeldin A (fig. S5), suggesting a
post-ER event.
During egress, SUB1 processes a family of cys-
teine proteases (SERAs) and a family of merozoite
surface proteins (MSPs) (15, 16). SERA5 is synthe-
sized as a 126-kDa protein and is processed se-
quentially by SUB1 into 73- and 56-kDa forms. The
latter is further processed into a 50-kDa fragment
in a SUB1-independent process (21). We assessed
SERA5 in PMXapt parasites. In the absence of aTc,
SERA5 accumulated in the 126-kDa form with
very little processing to other intermediates
(Fig. 3D). Similarly, MSP1 accumulated as its
193-kDa precursor (fig. S6). Thus, PMX KD im-
pairs downstream egress events.
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We tested whether PMX is an active protease
by introducing an ectopic gene copy (Fig. 3, E
and F, and fig. S7). PMXapt parasites constitutively
expressing a second-copy PMX gene with an
active site aspartate mutation [Asp266→Gly266
(D266G)] had reduced growth in the absence of
aTc and were unable to restore processing of
SUB1. In contrast, those expressing a wild-type
second-copy gene were rescued. These data show
that PMX enzymatic activity in vivo is crucial to
its function. The catalytic mutant PMX was pro-
cessed to the mature form, suggesting a trans-
processing event (fig. S7B).
Many aspartic protease inhibitors with anti-
malarial properties have been investigated, but
the specific targets for most of them are unknown
(1). Three aminohydantoins that caused schizont
accumulation reminiscent of our PMX KD pheno-
type were identified [TCMD-134675 and TCMD-
136879 from the TCAMS collection (22) and
CWHM-117 (11)]. To evaluate whether these com-
pounds act in a PMIX- or PMX-dependent man-
ner, dose-response curves were determined for KD
parasites. The half-maximal effective concentration
values were substantially lower for PMXapt but not
PMIXapt cultured in low-aTc conditions (Fig. 4, A
and B). This indicates hypersensitivity of PMXapt
parasites to aminohydantoins when PMX expres-
sion is low. Egress and invasion were blocked,
and an accumulation of abnormal schizonts was
observed by live-cell microscopy as shown with
CWHM-117 (Fig. 4, C and D). Further, treatment
of parasites with each of these inhibitors blocked
SUB1 and SERA5 maturation (Fig. 4E), as was
seen with PMXKD. Treatment with aminohydan-
toins did not block the initial SUB1 autoprocess-
ing step. The compounds also did not inhibit
PMX maturation (Fig. 4E). Recombinant PMX
cleaved a fluorogenic peptide as well as SUB1
protein in vitro, and these reactions were blocked
by aminohydantoins (Fig. 4F and fig. S9), with
median inhibitory concentration values from 175
to 800 nM in the peptide assay. Combining PMX
KD and inhibitor treatment resulted in a complete
block of egress and SUB1 maturation (Fig. 4, G
and H). Because CWHM-117 has oral efficacy in
a mouse model (11), it appears that PMX is a
promising target for antimalarial chemotherapy.
We have determined that PMIX and PMX are
essential for parasite egress and invasion. PMIX
localizes to the rhoptries and could be amaturase
for proteins in this organelle. We have discovered
that PMX is required for SUB1 processing,making
PMX the most upstream protease known in the
egress cascade (Fig. 4I). However, it is not clear
that the final cleavage of SUB1 is a direct action
of PMX; if so, it could result from processing of
semi-pro SUB1 or from cleavage of the prodomain,
liberating semi-pro SUB1 to process itself. PMX is
capable of cleaving SUB1 in vitro (fig. S9), adding
some support to the direct-cleavage model.
PMX does not appear to autoprocess (Fig. 4E
and fig. S7B), unlike most aspartic proteases,
which suggests that there may be another still-
undiscoveredmaturase upstream in the proteolytic
cascade of egress. We have identified compounds
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Fig. 1. PMIX is essential for invasion of erythrocytes; PMX is essen-
tial for egress and invasion. (A) Immunoblot with aFlag antibody
showing knockdown (KD) of PMIX and PMX after anhydrotetracycline
(aTc) withdrawal for one cycle. Haloacid dehalogenase–like hydrolase
(HAD1) was used as a loading control. (B) Expansion of PMIXapt and
PMXapt parasites is impaired in –aTc medium (P < 0.0001 for each by
two-tailed t test). Triangles, PMIXapt; circles, PMXapt. Open symbols,
–aTc; closed symbols, +aTc. (C and D) PMIX KD results in an invasion
defect. PMX KD results in both egress and invasion defects. Synchronized
ring-stage cultures were grown with or without aTc. Schizonts and rings were
counted by flow cytometry at 44 and 52 hours postinvasion (hpi). Shaded
bars, schizonts; open bars, rings. (C) 52-hour rings were fewer in the –aTc
condition [P < 0.0001 (t test)]. Number of schizonts was not significantly
different. (D) 52-hour rings were fewer in the –aTc condition (P < 0.0001).
Number of remaining schizonts was greater (P < 0.001). (E to G) Live-cell
microscopy of PMX parasites with or without aTc. (E) Individual schizonts
were scored for egress and subsequent invasion (arrows in image of control
parasite field). Scale bar, 5 mm. (F) Quantification of PMXapt egress and
invasion defects in the –aTc condition (**P < 0.01). (G) Abnormal schizont
classes observed after PMX KD: 1, distorted schizont; 2, unruptured
merozoite cluster; and 3, defective egress or merozoite dispersal. 4, Normal
schizont for comparison. Scale bars, 5 mm. All experiments in this and
subsequent figures were replicated at least three times. +aTc: 1 mM. Error
bars indicate SEM.
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Fig. 2. PMIX localizes to rhoptries,
whereas PMX localizes to exonemes.
(A and B) The PMIX gene was tagged with
3X hemagglutinin (HA) sequence at the 3′
end of the endogenous open reading frame.
Tagged parasites grew normally. Segmented
schizonts were prepared for immuno–electron
microscopy, and PMIX was visualized with
an anti-HA antibody and an 18-nm colloidal
gold-labeled secondary antibody. Colocaliza-
tion with an anti-RAP1 antibody, a marker for
rhoptries, was performed using a 12-nm
colloidal gold-labeled secondary antibody. The
arrowhead points to an 18-nm particle; the
arrow points to a 12-nm particle. (A) schizont;
(B) merozoite. (C and D) The PMX gene was
tagged with HA sequence. (C) Schizont; (D)
enlarged view of the boxed area in (C). (E) The
PMX gene was tagged with green fluorescent
protein (GFP) sequence, and the exoneme
marker SUB1 was tagged with 3X HA.
Segmented schizonts were prepared
for immuno–electron microscopy, PMX was
visualized with an anti-GFP antibody and
an 18-nm colloidal gold-labeled secondary
antibody, and SUB1 was visualized with an
anti-HA antibody and a 12-nm colloidal
gold-labeled secondary antibody. Two
examples are shown. Controls omitting the
primary antibody were negative in all cases.
(F and G) Electron micrographs of PMIXapt
cultured with (F) or without (G) aTc. Note the
apical granularity and discoid morphology
(G). See fig. S1 for statistics. Scale bars,
500 nm [(A) to (C), (F), and (G)]; 100 nm
(D); 200 nm (E). R, rhoptry; N, nucleus.
Fig. 3. Plasmepsin knockdowns impair schizont protein maturation.
(A) RAP1 maturation is impaired when PMIX is knocked down, but RON4
maturation is not. PMIXapt parasites were cultured with and without aTc to
44 hpi, and extracts were blotted for RAP1 (left) and RON4 (right). Arrows
mark precursor and processed RAP1 forms. (B) The second maturation
step in SUB1 processing is defective when PMX is knocked down. PMXapt
parasites were cultured as in (A). The rabbit anti-SUB1 immunoblot shows
54-kDa intermediate and 47-kDa mature SUB1 forms. (C) PMX expression
starts before SUB1 expression, but SUB1 maturation coincides with the peak
of mature PMX. HA-tagged PMX parasites were cultured for varying times.
Parasite extracts were processed for immunoblot using anti-HA or anti-SUB1
antibodies. Precursor (PMX, 67 kDa; SUB1, 54 kDa) and mature (PMX,
45 kDa; SUB1, 47 kDa) forms are marked at right. (D) Immunoblot
shows that processing of the SUB1 substrate SERA5 is impaired by PMX
KD. PMXapt parasites were cultured for 46 hpi (with and without aTc)
and processed for immunoblot. (E and F) A catalytically dead mutant
cannot rescue PMX KD. PMXapt parasites were complemented with a second
copy of the PMX gene, wild-type (WT) or mutant (D266G). Cultures were
maintained with and without aTc; parasitemia (E) and SUB1 processing (F)
were assessed. ****P < 0.0001 by two-tailed t test. KD of PMX and
expression of second-copy genes were confirmed by immunoblot (fig. S6).
ns, not significant. Error bars indicate SEM.
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with a common scaffold that are specific inhibitors
of PMX and that recapitulate the actions of PMX
KD phenotypically. Our PMIX and PMX lines
should allow high-throughput screening of as-
particprotease inhibitor collectionsandmay inform
efforts to improve on the promising CWHM-117
lead compound.
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Fig. 4. Aminohydantoin compounds act in a PMX-dependent manner
and phenocopy the PMX knockdown through a block in SUB1 processing.
(A and B) Dose-response curves for compounds incubated for 48 hours
with PMIXapt (A) or PMXapt (B) parasites at low (3 nM) or higher (10 nM)
aTc concentrations. Values are mean ± SEM (error bars). Growth of
parasites was similar at both aTc concentrations (fig. S8). (C and D)
CWHM-117 blocks egress at the same stage as PMX KD. Parental (NF54)
parasites were synchronized, treated with 500 nM CWHM-117 from 24 hpi,
and monitored for progression of egress by live cell microscopy, as in
Fig. 1. (C) Successful egress and invasion was scored. ****P < 0.0001.
(D) 1, distorted schizont; 2, merozoite cluster. Scale bars, 5 mm. (E) Amino-
hydantoins block the final SUB1 maturation step and impair processing of
downstream substrates. Compounds were applied to PMX-3X HA cultures
at 24 hpi and incubated for another 24 hours. Parasite extracts were
analyzed for immunoblot using antibodies to SUB1, SERA5, and HA (for
PMX). Cpd, compound; D, dimethyl sulfoxide (DMSO) vehicle control;
75, 0.2 mM TCMDC-134675; 79, 0.1 mM TCMDC-136879; 117, 0.5 mM CWHM-117.
(F) PMX assay. Recombinant PMX was incubated with fluorogenic
peptide for 120 min in the presence or absence of aminohydantoins.
Black, CWHM-117; green, TCMDC-136879; pink, TCMDC-134675. Error
bars, SEM. (G and H) PMX KD combined with inhibitor treatment
completely blocks egress (****P < 0.0001; ***P < 0.001) (G) and SUB1
maturation (H). Labels and concentrations are as in (E). (I) Scheme
of proteolytic cascade involved in egress.
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